Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. Co-located in New York City and Boston, we are a creative and multidisciplinary team of scientists, innovators and leaders dedicated to changing the way we approach drug development by establishing a powerful small-molecule modality for a wide variety of devastating diseases.
View Top Employees from Stablix, Inc.Website | http://www.stablix.com |
Employees | 28 (25 on RocketReach) |
Address | 450 East 29th Street Suite 502, New York, New York 10016, US |
Industry | Biotechnology |
Looking for a particular Stablix, Inc. employee's phone or email?
Tony Kingsley is the CEO of Stablix, Inc..
25 people are employed at Stablix, Inc..
Stablix, Inc. is based in New York, New York.